Xorte logo

News Markets Groups

USA | Europe | Asia | World| Stocks | Commodities



Add a new RSS channel

 
 


Keywords

2024-05-07 06:55:56| Mondaq.Com

After a political thriller, the proposed Platform Work Directive has finally taken its final form and is now set to be formally approved at the end of April...


Category: News and Media

 

LATEST NEWS

2024-05-07 06:51:04| Mondaq.Com

On April 7, 2024, Sen. Maria Cantwell, chair of the Senate Commerce Committee, and Rep. Cathy McMorris Rodgers, chair of the House Energy and Commerce Committee...


Category: News and Media

 

2024-05-07 06:47:13| The Economic Times

InCred equities recommend adding Ajanta Pharma, APL Apollo Tubes, Ashok Leyland, Aurobindo Pharma, and BCL Industries as top stock ideas for May.


Category: News and Media

 

Latest from this category

19.05Domestic copper at lifetime highs; factors affecting the price surge
19.05Explained: What are the advantages of marginal trading facility or MTF
19.05Q4 results this week: ITC, ONGC, Sun Pharma, Nykaa, Ircon International and IRFC
19.05Vedanta among 7 companies which declared dividends this week
19.05Trading journal is the most underrated risk mitigation technique. Heres a 5-step guide
19.05Big Funds bet the anything but bonds trade is poised to end
19.05Gold rallies on rate cut expectations amid US economy slowdown
19.05'I had no choice but to get a 35-year mortgage'
News and Media »

All news

19.05Domestic copper at lifetime highs; factors affecting the price surge
19.05Explained: What are the advantages of marginal trading facility or MTF
19.05Q4 results this week: ITC, ONGC, Sun Pharma, Nykaa, Ircon International and IRFC
19.05Vedanta among 7 companies which declared dividends this week
19.05Trading journal is the most underrated risk mitigation technique. Heres a 5-step guide
19.05Big Funds bet the anything but bonds trade is poised to end
19.05Gold rallies on rate cut expectations amid US economy slowdown
19.05'I had no choice but to get a 35-year mortgage'
More »
Privacy policy . Copyright . Contact form .